Uncategorized Archives - Page 15 of 137

FridayMay 24, 2024 9:45 am

Clene Inc. (NASDAQ: CLNN) Participates in Three Investor Conferences During May 2024, Promoting CNM-Au8(R) Neuronal Health Therapy

Clene recently participated in the Mizuho Neuroscience Summit 2024, the Benchmark 2024 Healthcare House Call Virtual Conference, and the Virtual A.G.P. Healthcare Conference CNM-Au8(R) is oral suspension developed to restore neuronal health and function by increasing energy production and utilization The therapy has been involved in clinical trials and compassionate use programs, accumulating over 600 years of exposure across various neurodegenerative conditions, with no safety concerns reported Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”), multiple sclerosis (“MS”), and Parkinson’s disease, recently…

FridayMay 24, 2024 9:00 am

PaxMedica Inc. (NASDAQ: PXMD) Seeking to Qualify for Neglected Tropical Disease Priority Review Voucher Program in Wake of Malawi Major Sleeping Sickness Crisis

PaxMedica has received an urgent plea from the Ministry of Health of Malawi for emergency access to IV suramin to prevent a potential humanitarian crisis due to dwindling supplies of essential drugs used to save lives in the region PaxMedica has previously concluded a Type B meeting with the FDA in preparation for the NDA submission, focusing on the use of PAX-101 in treating the rare and fatal trypanosomal infection, Trypanosoma brucei rhodesiense, transmitted by tsetse flies PaxMedica also aims to potentially qualify for a Priority Review Voucher under the Neglected Tropical Disease Priority Review Voucher Program, which could provide…

ThursdayMay 23, 2024 9:00 am

HealthLynked Corp. (HLYK) Can Add Tens-of-thousands of Members by Improving Care for Students vis-à-vis its Affinity Marketing Efforts to U.S. Universities

The HealthLynked platform provides secure and quick access for patient/doctor records communication, supporting all types of health related utilization, including telemedicine and remote student applications University health clinics often face challenges when transferring medical records – and this limits coordinated care for students The HealthLynked platform provides a streamlined approach to medical records access, allowing students to securely share their health information with relevant parties HealthLynked (OTCQB: HLYK) is a company on a mission to build a superior healthcare system through the efficient integration of patient histories, genetic data, and demographic insights, into a sophisticated AI-driven platform that streamlines patient care…

TuesdayMay 21, 2024 9:45 am

Clene Inc. (NASDAQ: CLNN) Announces Key Operational Highlights as part of First Quarter 2024 Financial Results

Clene presented clinical data at the 2024 American Academy of Neurology (“AAN”) Annual Meeting, demonstrating that long-term CNM-Au8® treatment resulted in significant evidence of repair and remyelination across multiple paraclinical endpoints Clene entered into a sub-award grant agreement with Columbia University under the previously announced National Institute of Health (“NIH”) Grant Clene announced the publication of “Protein Corona Composition of Gold Nanocatalysts” in the ACS Pharmacology & Translational Science journal Clene (NASDAQ: CLNN), a late-stage clinical biopharmaceutical company dedicated to revolutionizing the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), along with its wholly-owned subsidiary…

TuesdayMay 14, 2024 9:00 am

HealthLynked Corp. (HLYK) Setting New Standard for Efficient Healthcare, Including Virtual Healthcare

HealthLynked leverages innovative cutting-edge technology and connectivity to make healthcare more efficient for patients and doctors The company’s HealthLynked Network, a comprehensive and sophisticated cloud-based healthcare platform, connects patients, healthcare providers, and medical facilities, providing centralized information access and communication Through its sophisticated platform, HealthLynked is changing how patients and medical professionals can, for example, interact with telehealth and telemedicine services The network facilitates real-time interactions between healthcare providers and patients, greatly improving the efficient delivery of healthcare information and services remotely through a user-facing app, securely transmitting needed patient data on demand HealthLynked (OTCQB: HLYK) offers cutting-edge technology and…

FridayMay 10, 2024 9:45 am

Astiva Health Inc. Reshaping Landscape of Healthcare by Prioritizing Patient Engagement

Patient engagement can lead to reduced hospitalizations as well as improved effectiveness, efficiency, quality of health services, quality of life and responsiveness Healthcare industry players should address patient engagement as an imperative strategy Astiva Health recognizes that successful treatment outcomes are largely dependent on the patient, with 90% of treatment success attributed to patient involvement Growing research shows that patient engagement (“PE”) can have a significant impact on the outcome of a patient’s treatment. Recognizing that, Astiva Health is leading the way in offering a Medicare Advantage Prescription Drug (“MAPD”) health plan committed to reshaping the landscape of personalized and comprehensive healthcare…

MondayMay 06, 2024 10:30 am

HealthLynked Corp. (HLYK) Q4, FY2023 Financial Results; Show Bottom-line Improvements, Core Network Application Ramp-Up Expected in 2024

HealthLynked achieved significant optimization in operational expenses, resulting in a 70% reduction in net loss for the fourth quarter and highlighting a period of strategic positioning for future growth HealthLynked's full-year 2023 financial results mark technological advancements, with a focus on core technologies and profitability The company anticipates further performance improvements in the second half of 2024, positioning itself as a leader in healthcare technology HealthLynked (OTCQB: HLYK), a leader in healthcare networking and technological innovation, recently announced its financial results for the fourth quarter and full year ending December 31, 2023. HealthLynked achieved a significant 70% reduction in net…

MondayMay 06, 2024 9:00 am

Fentanyl Scourge: Nutriband Inc.’s (NASDAQ: NTRB) New Transdermal Patch with Abuse-Deterrent Tech Funded to Seek FDA Approval

150+ Americans die every day from synthetic opioid (e.g. fentanyl) overdose Nutriband’s AVERSA(TM) Fentanyl technology is being developed as an innovative solution to abuse and misuse rates in prescription opioid patch medications Nutriband raised $8.4 million in a private placement to fund AVERSA Fentanyl through FDA Approval Process Fentanyl addiction continues to devastate communities, with current treatment options facing limitations. However, as often happens in healthcare, innovation breeds hope with a new option on the horizon planning to seek FDA marketing approval. The challenges related to the powerful painkiller (up to 50x stronger than heroin and 100x stronger than morphine)…

ThursdayMay 02, 2024 10:30 am

Simplifying Healthcare Appointments: How HealthLynked Corp. (HLYK) is Revolutionizing Online Booking with a Patient-Focused Approach

In an era where convenience and efficiency stand as pillars of service delivery, HealthLynked (OTCQB: HLYK) has introduced an innovative online patient booking system, akin to how OpenTable simplifies restaurant reservations. This seamless integration of technology and healthcare is transforming how patients interact with medical services, ensuring that setting up a doctor's appointment is as easy as booking a dinner date. The Booking Process: Tailored for Simplicity and Flexibility HealthLynked's online booking system is designed with the user experience at the forefront. The process is straightforward: patients select their preferred doctor, date, and whether they prefer a morning or afternoon…

WednesdayMay 01, 2024 9:45 am

PaxMedica Inc. (NASDAQ: PXMD) Announces PAX-101 Batch Completion for NDA Application to FDA

PaxMedica has completed its three registration/validation batches of PAX-101, an IV formulation of suramin The completed batches are a significant step toward submitting a New Drug Application to the U.S. Food and Drug Administration in the fourth quarter of 2024 PaxMedica aims to establish a sustainable global supply chain for PAX-101 and to advance research and clinical trials targeting Autism Spectrum Disorder (“ASD”), demonstrating a steadfast commitment to addressing complex neurological conditions The ASD treatment market size was valued at $6.94 billion in 2022 and is projected to grow to $13.14 billion by 2030 PaxMedica (NASDAQ: PXMD), a biopharmaceutical company…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

Category: Uncategorized

Clene Inc. (NASDAQ: CLNN) Participates in Three Investor Conferences During May 2024, Promoting CNM-Au8(R) Neuronal Health Therapy

PaxMedica Inc. (NASDAQ: PXMD) Seeking to Qualify for Neglected Tropical Disease Priority Review Voucher Program in Wake of Malawi Major Sleeping Sickness Crisis

HealthLynked Corp. (HLYK) Can Add Tens-of-thousands of Members by Improving Care for Students vis-à-vis its Affinity Marketing Efforts to U.S. Universities

Clene Inc. (NASDAQ: CLNN) Announces Key Operational Highlights as part of First Quarter 2024 Financial Results

HealthLynked Corp. (HLYK) Setting New Standard for Efficient Healthcare, Including Virtual Healthcare

Astiva Health Inc. Reshaping Landscape of Healthcare by Prioritizing Patient Engagement

HealthLynked Corp. (HLYK) Q4, FY2023 Financial Results; Show Bottom-line Improvements, Core Network Application Ramp-Up Expected in 2024

Fentanyl Scourge: Nutriband Inc.’s (NASDAQ: NTRB) New Transdermal Patch with Abuse-Deterrent Tech Funded to Seek FDA Approval

Simplifying Healthcare Appointments: How HealthLynked Corp. (HLYK) is Revolutionizing Online Booking with a Patient-Focused Approach

PaxMedica Inc. (NASDAQ: PXMD) Announces PAX-101 Batch Completion for NDA Application to FDA

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search